Eureka Therapeutics

06/23/2025

Reminder: Hepatoblastoma Patient & Family Advocacy Day is coming up on June 25, 2025!

Families impacted by hepatoblastoma will come together at UCSF Mission Bay for a meaningful day of education, connection, and support during the 5th International Pediatric Liver Tumor Research Meeting.

Eureka Therapeutics is honored to speak at the evening dinner, where we’ll share insights into pediatric liver cancer and our ongoing ARYA-2 clinical trial.

Don’t miss this opportunity to learn, connect, and stand united in the fight against hepatoblastoma.

Register here: https://www.hepatoblastoma.org/2025-conference

Hepatoblastoma Resource Network

Join us in San Francisco on June 25th, 2025 for the Patient & Family Advocacy day.

06/16/2025

Come and join us at the 5th International Pediatric Liver Tumor Research Meeting – Hepatoblastoma Patient & Family Advocacy Day, taking place on Wednesday, June 25, 2025 at UCSF Mission Bay Conference Center. Eureka Therapeutics is proud to sponsor the community dinner at 6:00 PM, following a full day of inspiring sessions and connection.

Hosted by UCSF Benioff Children's Hospitals, this free, in-person event brings together families, survivors, clinicians, and researchers to explore the latest advances in pediatric liver tumor research and care.

Learn more and register: https://www.hepatoblastoma.org/2025-conference

Hepatoblastoma Resource Network

06/03/2025

Check out a recap of the webinar featuring a unique perspective on the rare pediatric liver cancer.

Julie Chessell, nurse and mother, shared her son’s life-saving transplant journey — blending medical insight with personal experience.

Dr. Nicole Nunez from Eureka Therapeutics, discussed cutting-edge T-cell therapy and the ARYA-2 clinical trial for pediatric liver cancers.

The session includes a Q&A with audience-submitted questions.

Watch now:

This webinar, in honor of Hepatoblastoma Awareness Day, explores this rare pediatric cancer through the eyes of someone with a unique perspective—a parent ad...

05/21/2025

Just a reminder — our special free virtual webinar in honor of Hepatoblastoma Awareness Day is happening this Friday, May 23 at 9:00 AM PST!

Join us for an inspiring and informative session featuring Julie Chessell, a nurse and parent advocate, who will share insights from both sides of the patient-care experience, and Dr. Nicole Nunez of Eureka, who will present the latest advancements from our ARYA-2 clinical trial for pediatric liver cancers.

🗓️ Webinar: “Hepatoblastoma: A Parent and Nurse Perspective”
🕘 Date & Time: Friday, May 23 | 9:00 AM PST
📍 Where: Virtual
🔗 RSVP here: ab1b7c61-20d5-462a-a7ae-99265f124e20@19dbd99e-c660-4242-b8f3-9e99111e2c21" rel="ugc" target="_blank">https://events.teams.microsoft.com/event/ab1b7c61-20d5-462a-a7ae-99265f124e20@19dbd99e-c660-4242-b8f3-9e99111e2c21

05/14/2025

In recognition of Hepatoblastoma Awareness Day, Eureka Therapeutics will host a special free virtual webinar on Friday, May 23 at 9:00 AM PST exploring this rare pediatric liver cancer through the unique lens of Julie Chessell — a nurse and parent advocate — who will share her son’s life-saving transplant journey, blending her professional and personal insights.

We’ll also hear from Dr. Nicole Nunez of Eureka, who will present the latest developments in T-cell therapy for pediatric liver cancers, including the ARYA-2 clinical trial. The session will conclude with a live Q&A, so bring your questions!

🗓️ Title: “Hepatoblastoma: A Parent and Nurse Perspective”
📅 Date: Friday, May 23, 2025
🕘 Time: 9:00 AM PST
📍 Where: Online
🔗 RSVP here: ab1b7c61-20d5-462a-a7ae-99265f124e20@19dbd99e-c660-4242-b8f3-9e99111e2c21" rel="ugc" target="_blank">https://events.teams.microsoft.com/event/ab1b7c61-20d5-462a-a7ae-99265f124e20@19dbd99e-c660-4242-b8f3-9e99111e2c21

02/24/2025

Mark your calendar for Dr. Bryan Zimdahl’s presentation at the CAR-TCR Summit Europe on Feb 25th at 10 AM in London, where he will be sharing insights to accelerate IND & clinical program development while navigate the ever-evolving regulatory landscape for product consistency.

Register at https://cartcr-europe.com

Join 300+ industry experts in London at the 8th CAR-TCR Summit to spearhead innovation in armouring and gene engineering with streamlined manufacturing to develop clinically durable cost-effective cell therapies.

02/24/2025

Eureka Therapeutics’s next stop is London, UK!

We are excited to attend the CAR-TCR Summit Europe from Feb 25-27. Dr. Bryan Zimdahl will be presenting “Regulatory Insights and Best Practices for Advancing Autologous T-Cell Therapies in Early Clinical Stages”.

Save a spot today: https://cartcr-europe.com

Join 300+ industry experts in London at the 8th CAR-TCR Summit to spearhead innovation in armouring and gene engineering with streamlined manufacturing to develop clinically durable cost-effective cell therapies.

02/19/2025

Don’t miss our booth and poster session at HCC-LIVE Conference tomorrow!

Explore the transformative ARTEMIS Cell Receptor Platform, an innovative technology that delivers the next-generation . It has the potential to offer safer treatments and expand accessibility beyond specialized centers. Register now at https://hcc-live.org.

02/12/2025

Join Eureka Therapeutics at HCC-LIVE Conference in Austin from Feb 20-22, where we will be showcasing our ARTEMIS Cell Receptor Platform, providing a potentially safer and more efficacious approach to for cancers. Stop by our booth and poster to learn more about ARYA-2 (NCT04634357) & ARYA-3 (NCT04864054) for .

09/12/2024

In honor of Childhood Cancer Awareness Month in September, Eureka Therapeutics will host a special webinar featuring Dr. Allison O’Neill of Dana Farber/Boston Children’s Cancer Institute and Dr. Rangaswami of UCSF Benioff Children's Hospitals who will talk about childhood liver cancer diagnosis, treatment options and clinical trials available to patients, as well as have a live Q&A section so you can ask your questions directly to the physicians! The webinar is happening September 20th, 11-noon PST. To register for this free live webinar event, please visit: https://bit.ly/3MtTaAm

05/28/2024

In honor of Day, Eureka's Dr. Nicole Nunez and Allison Chaffee discuss hepatoblastoma, a rare form of , with a special guest Christina Stiverson, the founder of The Hepatoblastoma Resource Network and Addie’s Research Foundation.

In the interview video, we shared our understanding of what is, who it impacts, and potential treatment options. We also discussed Eureka's ARYA-2 clinical trial, a T-cell therapy to treat pediatric patients with liver cancers. Watch here:

In honor of Hepatoblastoma Awareness Day, our host, Allison Chaffee of Eureka Therapeutics, discusses hepatoblastoma, a rare form of pediatric liver cancer, ...

04/02/2024

Exciting news! UCSF Benioff Children's Hospitals joins Eureka's ARYA-2 trial as 1st CA site to offer anti-AFP ARTEMIS T-cell therapy for pediatric liver cancer. We're very proud to partner with California Institute for Regenerative Medicine and UCSF Benioff Children's Hospitals to help young liver cancer patients in need.
Click to learn more: https://shorturl.at/lMNX9